Camber Capital Management

Camber Capital Management as of March 31, 2019

Portfolio Holdings for Camber Capital Management

Camber Capital Management holds 28 positions in its portfolio as reported in the March 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf (SPY) 14.1 $283M 1.0M 282.48
Allergan 9.5 $190M 1.3M 146.41
Mylan Nv 8.1 $163M 5.8M 28.34
Perrigo Company (PRGO) 5.0 $101M 2.1M 48.16
Global Blood Therapeutics In 4.8 $95M 1.8M 52.93
Biogen Idec (BIIB) 4.7 $95M 400k 236.38
Universal Health Services (UHS) 4.3 $87M 650k 133.77
DaVita (DVA) 4.1 $81M 1.5M 54.29
Alexion Pharmaceuticals 4.0 $81M 600k 135.18
Atara Biotherapeutics (ATRA) 4.0 $80M 2.0M 39.75
Brookdale Senior Living (BKD) 3.6 $72M 11M 6.58
Medicines Company 3.4 $69M 2.5M 27.95
Nektar Therapeutics (NKTR) 3.4 $67M 2.0M 33.60
Sarepta Therapeutics (SRPT) 3.0 $60M 500k 119.19
Momenta Pharmaceuticals 2.9 $58M 4.0M 14.53
Teva Pharmaceutical Industries (TEVA) 2.7 $55M 3.5M 15.68
Bristol Myers Squibb (BMY) 2.6 $53M 1.1M 47.71
Ascendis Pharma A S (ASND) 2.5 $51M 430k 117.70
Tenet Healthcare Corporation (THC) 2.5 $51M 1.8M 28.84
NuVasive 2.1 $43M 750k 56.79
Synthorx 1.9 $38M 1.9M 20.37
Clovis Oncology 1.9 $37M 1.5M 24.82
Zymeworks 1.8 $35M 2.2M 16.18
AMAG Pharmaceuticals 1.7 $34M 2.7M 12.88
Eagle Pharmaceuticals (EGRX) 0.7 $15M 292k 50.49
Sutro Biopharma (STRO) 0.3 $6.8M 600k 11.39
Endologix 0.3 $6.1M 930k 6.61
Surgery Partners (SGRY) 0.1 $1.8M 160k 11.28